|
|
Ruptured Retinal Arterial Macroaneurysm - Submacular hemorrhage and BRAOvaatamisi: 16881 year old female with vision loss for a few days. Coumadin was high with INR at 3.1 VA 6/200dets 21, 2024
|
|
Ruptured Retinal Arterial Macroaneurysm - Submacular hemorrhage and BRAOvaatamisi: 15981 year old female with vision loss for a few days. Coumadin was high with INR at 3.1 VA 6/200dets 21, 2024
|
|
Ruptured Retinal Arterial Macroaneurysm - Submacular hemorrhage and BRAOvaatamisi: 14281 year old female with vision loss for a few days. Coumadin was high with INR at 3.1 VA 6/200dets 21, 2024
|
|
Ruptured Retinal Arterial Macroaneurysm - Submacular hemorrhage and BRAOvaatamisi: 15181 year old female with vision loss for a few days. Coumadin was high with INR at 3.1 VA 6/200dets 21, 2024
|
|
54 year old female with a lot of drusenvaatamisi: 180VA 20/12 OD, 20/16 OS - no symptomsdets 21, 2024
|
|
54 year old female with a lot of drusenvaatamisi: 184VA 20/12 OD, 20/16 OS - no symptomsdets 21, 2024
|
|
54 year old female with a lot of drusenvaatamisi: 177VA 20/12 OD, 20/16 OS - no symptomsdets 21, 2024
|
|
54 year old female with a lot of drusenvaatamisi: 181VA 20/12 OD, 20/16 OS - no symptomsdets 21, 2024
|
|
54 year old female with a lot of drusenvaatamisi: 200VA 20/12 OD, 20/16 OS - no symptomsdets 21, 2024
|
|
54 year old female with a lot of drusenvaatamisi: 198VA 20/12 OD, 20/16 OS - no symptomsdets 21, 2024
|
|
54 year old female with a lot of drusenvaatamisi: 185VA 20/12 OD, 20/16 OS - no symptomsdets 21, 2024
|
|
54 year old female with a lot of drusenvaatamisi: 201VA 20/12 OD, 20/16 OS - no symptomsdets 21, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 13177 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 16177 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 12577 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 13277 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 13677 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 11977 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 11977 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 12677 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 12177 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 17577 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 17777 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 14477 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 12377 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 14277 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 16377 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 10977 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 14977 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 12477 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 11677 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 14677 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 16777 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 14377 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Wet AMD - Occult CNVM and Geographic atrophyvaatamisi: 15277 year old female with mild vision loss - 20/32 - responded to Avastindets 19, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 24458 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 25558 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 32758 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 16758 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 15858 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 15458 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 16858 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 13458 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 15658 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 14858 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 13458 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 14258 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 13758 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 14358 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 16058 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 15258 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 13858 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 12758 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 15358 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 13658 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 13158 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 12058 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 12558 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 13958 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 14158 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 15058 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 14358 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 12458 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 16258 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Choroidal Metastatic Breast Cancer with Exudative Detachmentvaatamisi: 14958 year old female presented with 20/200 vision. Had 10 sessions of radiation and tumor shrank. The exudative detachment took almost a year to resolve. The vision improved to 20/40.nov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 16280 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 13380 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 14880 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 15880 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 14580 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 14380 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 17380 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 13580 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 12680 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 18180 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 15080 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 17480 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 13880 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 16180 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 15680 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 14480 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 15380 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 13580 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 14380 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 13680 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 13780 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 11680 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 12580 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 13280 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 14180 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 15080 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 11680 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 12980 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 14380 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 15480 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 14280 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 16380 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Myopic CNVM Left Eyevaatamisi: 18080 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmonov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 12074 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
Pseudophakic CME chronicvaatamisi: 14874 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timololnov 06, 2024
|
|
|
|
